NO20083876L - Doseformer for administrering av combinasjonsmedikamenter - Google Patents

Doseformer for administrering av combinasjonsmedikamenter

Info

Publication number
NO20083876L
NO20083876L NO20083876A NO20083876A NO20083876L NO 20083876 L NO20083876 L NO 20083876L NO 20083876 A NO20083876 A NO 20083876A NO 20083876 A NO20083876 A NO 20083876A NO 20083876 L NO20083876 L NO 20083876L
Authority
NO
Norway
Prior art keywords
dosage forms
administration
combination
absorption
drugs
Prior art date
Application number
NO20083876A
Other languages
English (en)
Norwegian (no)
Inventor
John R Plachetka
Donna L Gilbert
Original Assignee
Pozen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pozen Inc filed Critical Pozen Inc
Publication of NO20083876L publication Critical patent/NO20083876L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20083876A 2006-03-06 2008-09-10 Doseformer for administrering av combinasjonsmedikamenter NO20083876L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77937306P 2006-03-06 2006-03-06
US11/712,969 US20070207200A1 (en) 2006-03-06 2007-03-02 Dosage forms for administering combinations of drugs
PCT/US2007/005266 WO2007103113A2 (fr) 2006-03-06 2007-03-02 Formes pharmaceutiques pour l'administration d'associations de medicaments

Publications (1)

Publication Number Publication Date
NO20083876L true NO20083876L (no) 2008-12-02

Family

ID=38471739

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083876A NO20083876L (no) 2006-03-06 2008-09-10 Doseformer for administrering av combinasjonsmedikamenter

Country Status (13)

Country Link
US (1) US20070207200A1 (fr)
EP (1) EP1993518A4 (fr)
JP (1) JP5349059B2 (fr)
CN (1) CN101410095B (fr)
AU (1) AU2007224229B2 (fr)
BR (1) BRPI0708640A8 (fr)
CA (1) CA2644435C (fr)
EA (1) EA020867B1 (fr)
HK (1) HK1128230A1 (fr)
IL (1) IL193727A (fr)
MX (1) MX2008011441A (fr)
NO (1) NO20083876L (fr)
WO (1) WO2007103113A2 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US20060178349A1 (en) * 2005-01-24 2006-08-10 Pozen Inc. Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID
WO2008074153A1 (fr) 2006-12-18 2008-06-26 Electronic Dietary Foods Inc. Dispositif d'administration d'une substance
GB0625646D0 (en) * 2006-12-21 2007-01-31 Jagotec Ag Improvements in or relating to organic compounds
BRPI0700133A (pt) * 2007-01-29 2008-09-16 Incrementha P D & I Pesquisa D composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
US20090068262A1 (en) * 2007-04-04 2009-03-12 Ilan Zalit Rapid dissolution of combination products
MX2010000803A (es) * 2007-07-20 2010-06-23 Abbott Gmbh & Co Kg Formulaciones de analgesicos no opioides y opioides confinados.
GB0714790D0 (en) * 2007-07-30 2007-09-12 Jagotec Ag Improvements in or relating to organic compounds
JP5453280B2 (ja) * 2007-10-16 2014-03-26 ラボファーム インコーポレイテッド アセトアミノフェンおよびトラマドールを持続的に放出するための二層組成物
PT2057984E (pt) * 2007-11-09 2010-03-10 Acino Pharma Ag Comprimidos retard com hidromorfona
US20090186086A1 (en) * 2008-01-17 2009-07-23 Par Pharmaceutical, Inc. Solid multilayer oral dosage forms
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
JP5607550B2 (ja) 2008-03-11 2014-10-15 ディポメド，インコーポレイティド 非オピオイド鎮痛剤及びオピオイド鎮痛剤の組合せを含む胃保持性持続放出剤形
US20090252791A1 (en) * 2008-04-02 2009-10-08 Venkata Nookaraju Sreedharala Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
EP2756756B1 (fr) * 2008-04-28 2016-01-06 Zogenix, Inc. Compositions inédites destinées au traitement de la migraine
AU2013202680C1 (en) * 2008-04-28 2016-06-23 Zogenix, Inc. Novel formulations for treatment of migraine
CA2765866C (fr) * 2008-06-20 2016-06-21 Alphapharm Pty Ltd Composition pharmaceutique monophasee d'un inhibiteur 5-ht1 et d'un ains
US20100008986A1 (en) * 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Pharmaceutical compositions comprising sumatriptan and naproxen
EP2344139A1 (fr) 2008-09-09 2011-07-20 AstraZeneca AB Procédé d'administration d'une composition pharmaceutique à un patient en ayant besoin
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
US9198861B2 (en) * 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
WO2011087765A2 (fr) * 2009-12-22 2011-07-21 Mallinckrodt Inc. Procédés de production de compositions pharmaceutiques galéniques solides stabilisées contenant des morphinanes
US20110150989A1 (en) * 2009-12-22 2011-06-23 Mallinkckrodt Inc. Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
US20120015031A1 (en) * 2010-07-14 2012-01-19 Grunenthal Gmbh Novel gastro-retentive dosage forms
CN101987092A (zh) * 2010-09-27 2011-03-23 苏州世林医药技术发展有限公司 含有镇痛剂的新型药学组成物
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
AU2012336030B2 (en) 2011-11-07 2017-09-14 Nektar Therapeutics Compositions, dosage forms, and coadministration of an opioid agonist compound and an analgesic compound
US10525054B2 (en) 2011-11-07 2020-01-07 Inheris Biopharma, Inc. Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
CN103385876B (zh) * 2012-05-08 2016-01-13 四川滇虹医药开发有限公司 一种夫罗曲坦的药物组合物及其制备方法
MX2013008995A (es) * 2013-08-02 2014-03-24 Raam De Sahuayo S A De C V Lab Composicion farmaceutica para el tratamiento del dolor.
MX362435B (es) * 2013-08-02 2019-01-17 Laboratorio Raam De Sahuayo S A De C V Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion.
WO2015023675A2 (fr) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération immédiate
CN104434918A (zh) * 2013-09-16 2015-03-25 江苏恩华药业股份有限公司 盐酸羟考酮与布洛芬复方多层片及其制备方法
WO2015095391A1 (fr) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération prolongée
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US20150209360A1 (en) * 2014-01-30 2015-07-30 Orbz, Llc Oral caffeine delivery composition
WO2016010771A1 (fr) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Forme posologique remplie de liquide anti-abus à libération immédiate
AU2015330937B2 (en) * 2014-10-08 2021-07-15 Theriva Biologics, Inc. Beta-lactamase formulations and uses thereof
JP2017531026A (ja) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 徐放性乱用抑止性液体充填剤形
CN104523709A (zh) * 2014-12-22 2015-04-22 青岛正大海尔制药有限公司 一种含有琥珀酸夫罗曲坦的复方缓释制剂
KR101710792B1 (ko) * 2015-07-14 2017-02-28 주식회사 유영제약 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물
CN109700816B (zh) * 2018-12-29 2020-10-16 南通励成生物工程有限公司 磷脂酰丝氨酸肠溶包衣制剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
DE69222006T2 (de) * 1991-10-30 1998-01-22 Glaxo Group Ltd Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
DE19601477C2 (de) * 1996-01-17 1999-12-16 Axel Kirsch Befestigungsnagel
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
US6599529B1 (en) * 1997-09-11 2003-07-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs)
DE19901687B4 (de) * 1999-01-18 2006-06-01 Grünenthal GmbH Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
MXPA05004422A (es) * 2002-10-25 2007-11-22 Collegium Pharmaceutical Inc Composiciones de milnacipran de liberacion pulsatil.
JP4616009B2 (ja) * 2002-12-26 2011-01-19 ポーゼン インコーポレイテッド ＮＳＡＩＤｓおよびトリプタンを含有する多層剤型
EP1631263B1 (fr) * 2003-06-06 2014-02-26 Ethypharm Comprime orodispersible multicouche
FR2855756B1 (fr) * 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
WO2004110492A2 (fr) * 2003-06-06 2004-12-23 Glaxo Group Limited Composition pharmaceutique
KR20070036797A (ko) * 2004-07-26 2007-04-03 테바 파마슈티컬 인더스트리즈 리미티드 장용 코팅된 중심정을 갖는 제형

Also Published As

Publication number Publication date
IL193727A (en) 2015-07-30
EA020867B1 (ru) 2015-02-27
AU2007224229B2 (en) 2012-10-11
CN101410095B (zh) 2015-07-01
CN101410095A (zh) 2009-04-15
EP1993518A2 (fr) 2008-11-26
BRPI0708640A2 (pt) 2011-06-07
IL193727A0 (en) 2009-05-04
AU2007224229A1 (en) 2007-09-13
WO2007103113A3 (fr) 2007-11-01
JP2009539761A (ja) 2009-11-19
MX2008011441A (es) 2008-11-18
EP1993518A4 (fr) 2012-12-12
US20070207200A1 (en) 2007-09-06
EA200870325A1 (ru) 2009-02-27
JP5349059B2 (ja) 2013-11-20
HK1128230A1 (en) 2009-10-23
CA2644435C (fr) 2015-04-07
BRPI0708640A8 (pt) 2018-04-24
CA2644435A1 (fr) 2007-09-13
WO2007103113A2 (fr) 2007-09-13

Similar Documents

Publication Publication Date Title
NO20083876L (no) Doseformer for administrering av combinasjonsmedikamenter
Viscusi et al. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability
EP2444072A3 (fr) Formes galéniques de film non mucoadhésifs
WO2006069293A3 (fr) Composition pour traitement de la douleur
IL194885A0 (en) Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid
WO2006008639A8 (fr) Traitement combine pour malignites non hematologiques par anticorps anti -ogf-1r
WO2003057170A8 (fr) Insulinotherapie par voie orale
MX2009005339A (es) Suspensiones analgesicas de liberacion modificada.
RU2007132181A (ru) ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ
AR052052A1 (es) Terapia de combinacion
BRPI0510895A (pt) formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t
NO20075393L (no) Akarbosebaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse
NO20080244L (no) Doseringsstyring for prasugrel
AR065139A1 (es) Medicamento para el tratamiento de la endometriosis
CN100569269C (zh) 止痛药
WO2006124573A3 (fr) Traitement du cancer a l'aide de 2-desoxyglucose
Chung et al. Long‐term follow‐up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension
Moffa et al. Bromelain after oral or dental procedures: an update
RU2007116477A (ru) Способ лечения бактериальных гнойных менингитов у детей
WO2008079818A3 (fr) Administration intraveineuse de formulations analgésiques hydrosolubles
JP2013523844A5 (fr)
RU2008103666A (ru) Способ лечения острой аллергии и устройство для доставки лекарственного средства
Wyndaele et al. MP-05.02 Combination Therapy with Tamsulosin OCAS™ and Solifenacin is more Effective than Solifenacin Monotherapy as a Treatment for Male LUTS Associated with BPH: Results from the SATURN Trial
PIÑA Supra-additive interaction of docosahexaenoic acid and naproxen and gastric safety on the formalin test in rats
Huffman Loratadine and fluticasone nasal spray: Added benefit?

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application